Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5
slide-6
slide-7

Glimisave M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Eris Lifesciences Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimisave M 1 Tablet PR

This medication, Glimisave M 1 Tablet PR, is an antidiabetic combination therapy for adult patients with type 2 diabetes. It manages blood glucose levels, ideally taken with meals at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This drug is just one component of a comprehensive diabetes management plan, which necessitates a healthy diet, regular exercise, and weight management as directed by your doctor. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with its symptoms – sweating, dizziness, headache, and tremors – and appropriate countermeasures, such as readily available glucose sources (e.g., sugary snacks, fruit juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a potential consequence for some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimisave M 1 Tablet PR

No text provided to rephrase.

Uses of Glimisave M 1 Tablet PR

Managing Type 2 diabetes

Major Benefits of Glimisave M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Take one Glimisave M tablet with food.

Common Side effects of Glimisave M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimisave M 1 Tablet PR:

Follow your physician's instructions or consult the product label for guidance prior to administration. Ingest Glimisave M 1 Tablet PR with a meal.

How Glimisave M 1 Tablet PR works:

Glimisave M 1 Tablet PR combines glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's response to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimisave M 1 Tablet PR with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimisave M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Using Glimisave M 1 Tablet PR while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimisave M 1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimisave M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically recommended for those with mild to moderate liver disease; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimisave M 1 Tablet PR :

Should you forget a Glimisave M 1 Tablet PR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosage routine. Avoid taking a double dose.

Facts to Know About Glimisave M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Glimisave M 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimisave M 1 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimisave M 1 Tablet PR and seek immediate medical attention.
Glimisave M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimisave M 1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimisave M 1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimisave M 1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimisave M 1 Tablet PR with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Glimisave M 1 Tablet PR
127
MRP 147
13% off